Actively Recruiting
Ward Admission of Haematuria: an Observational Multicentre Study
Led by British Urology Researchers in Surgical Training · Updated on 2026-02-09
1050
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting an international, multicenter observational study to understand how patients admitted to hospitals with emergency haematuria are managed. The study aims to identify variations in care, measure outcomes like length of hospital stay, mortality, readmission rates, and resource use, and support the development of future guidelines and trials to improve haematuria management. The study collects detailed data on patient demographics, underlying health conditions, diagnostic procedures, treatments, and outcomes using a standardized form. It includes patients admitted as emergencies with haematuria under urology care. The study observes current hospital management pathways and gathers information through questionnaires to participating sites. Participants will be followed during their hospital stay and for 90 days afterward. Researchers will evaluate length of stay, time to diagnosis, mortality at 30 and 90 days, readmissions, days alive and out of hospital, and healthcare costs. The study uses data analysis to assess factors linked to outcomes and variations in care. Participation involves no changes to treatment as it is observational, and data will be collected consecutively over a 12-month period from multiple centers.
CONDITIONS
Brief Title
A Study of Ward Admissions for Haematuria
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients are included if they are over 16 years of age or older and admitted to a participating urological secondary care centre
- Admitted as an emergency with haematuria as the primary or secondary diagnosis under the primary or joint care of urology
You will not qualify if you...
- Any patients under 16 years of age
- Patients with catheter-related urethral trauma defined as haematuria immediately after insertion of a urethral catheter that was documented as traumatic by the clinician, with no previous history of haematuria prior to catheter insertion
- Patients that are in hospital less than 24 hours
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 90 days from admission
Participants who are admitted as emergencies with haematuria are observed to collect data on management practices, clinical outcomes, and resource use during their hospital stay and up to 90 days after discharge.
Data collected during hospital admission and follow-up assessments up to 90 days
Trial Site Locations
Total: 1 location
1
BURST
London, United Kingdom
Actively Recruiting
Research Team
K
Kevin Byrnes, PhD
N
Nikita Bhatt, FRCS
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here